TISSUE DISTRIBUTION OF DOXORUBICIN AND DOXORUBICINOL IN RATS RECEIVING MULTIPLE DOSES OF DOXORUBICIN

被引：3
|
作者：
PETERS, JH
GORDON, GR
KASHIWASE, D
ACTON, EM
机构：
来源：
CANCER CHEMOTHERAPY AND PHARMACOLOGY | 1981年 / 7卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：65 / 69
页数：5
相关论文
共 50 条
  • [1] DOXORUBICINOL - THE CULPRIT IN DOXORUBICIN CARDIOTOXICITY
    MUSHLIN, PS
    BOUCEK, RJ
    BRENNER, DE
    CUSACK, BJ
    FLEISCHER, S
    OLSON, RD
    FEDERATION PROCEEDINGS, 1986, 45 (03) : 195 - 195
  • [2] DOXORUBICIN AND DOXORUBICINOL PHARMACOKINETICS AND TISSUE CONCENTRATIONS FOLLOWING BOLUS INJECTION AND CONTINUOUS INFUSION OF DOXORUBICIN IN THE RABBIT
    CUSACK, BJ
    YOUNG, SP
    DRISKELL, J
    OLSON, RD
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1993, 32 (01) : 53 - 58
  • [3] CYTOFLUORESCENCE LOCALIZATION AND DISPOSITION OF DOXORUBICIN AND DOXORUBICINOL IN RAT CARDIAC TISSUE
    DANESI, R
    PAPARELLI, A
    BERNARDINI, N
    DELTACCA, M
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1988, 24 (07): : 1123 - 1131
  • [4] Analysis of doxorubicin and doxorubicinol in rat myocardia
    Anderson, M. Jennifer
    Karnilaw, Peter
    Jensen, M. S. Brock
    Hayward, Reid
    Hyslop, Richard M.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 239
  • [5] THE EFFECT OF PHENYTOIN ON DOXORUBICIN AND DOXORUBICINOL PHARMACOKINETICS
    CUSACK, BJ
    TESNOHLIDEK, DA
    LOSEKE, VL
    VESTAL, RE
    BRENNER, DE
    OLSON, RD
    CLINICAL RESEARCH, 1988, 36 (01): : A117 - A117
  • [6] Analysis of the Doxorubicin and Doxorubicinol in the Plasma of Breast Cancer Patients for Monitoring the Toxicity of Doxorubicin
    Harahap, Yahdiana
    Ardiningsih, Puspitasari
    Winarti, Agatha Corintias
    Purwanto, Denni Joko
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2020, 14 : 3469 - 3475
  • [7] EFFECT OF PHENYTOIN ON DOXORUBICIN AND DOXORUBICINOL PHARMACOKINETICS IN THE RABBIT
    CUSACK, BJ
    TESNOHLIDEK, DA
    LOSEKE, VL
    VESTAL, RE
    BRENNER, DE
    OLSON, RD
    CLINICAL RESEARCH, 1988, 36 (03): : A362 - A362
  • [8] DOXORUBICINOL - A MORE POTENT CARDIOTOXIN THAN DOXORUBICIN
    OLSON, RD
    BRENNER, DE
    MUSHLIN, PS
    BOERTH, RC
    HANDE, KR
    BOUCEK, RJ
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1985, 26 (MAR): : 227 - 227
  • [9] EFFECT OF PHENYTOIN ON THE PHARMACOKINETICS OF DOXORUBICIN AND DOXORUBICINOL IN THE RABBIT
    CUSACK, BJ
    TESNOHLIDEK, DA
    LOSEKE, VL
    VESTAL, RE
    BRENNER, DE
    OLSON, RD
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1988, 22 (04) : 294 - 298
  • [10] DOXORUBICIN CARDIOTOXICITY MAY BE CAUSED BY ITS METABOLITE, DOXORUBICINOL
    OLSON, RD
    MUSHLIN, PS
    BRENNER, DE
    FLEISCHER, S
    CUSACK, BJ
    CHANG, BK
    BOUCEK, RJ
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (10) : 3585 - 3589
12345